Published in Arch Dis Child on March 01, 1990
Microbiology of cystic fibrosis lung infections: themes and issues. J R Soc Med (1993) 1.46
Development of a PCR probe test for identifying Pseudomonas aeruginosa and Pseudomonas (Burkholderia) cepacia. J Clin Pathol (1994) 1.33
IgG antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis. Arch Dis Child (1992) 1.26
Diagnostic and prognostic value of serum antibodies against Pseudomonas aeruginosa in cystic fibrosis. Thorax (2006) 1.01
Interference of immunoglobulin G (IgG) antibodies in IgA antibody determinations of Chlamydia pneumoniae by microimmunofluorescence test. J Clin Microbiol (1994) 0.96
Translocated LPS might cause endotoxin tolerance in circulating monocytes of cystic fibrosis patients. PLoS One (2011) 0.86
Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child (1958) 9.70
The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol (1974) 5.03
Monoclonal antibodies against Pseudomonas aeruginosa outer membrane antigens: isolation and characterization. Infect Immun (1982) 2.61
Expression of immune mechanisms in the lung. Am Rev Respir Dis (1976) 2.24
Bacterial flora of respiratory tract in patients with cystic fibrosis, 1950-71. Arch Dis Child (1972) 1.89
Some aspects of immunity in patients with cystic fibrosis. Clin Exp Immunol (1974) 1.60
Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis. Arch Dis Child (1986) 1.49
Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme-linked immunosorbent assay. J Clin Microbiol (1987) 1.49
Serum IgG antibodies in patients with cystic fibrosis with early Pseudomonas aeruginosa infection. Arch Dis Child (1987) 1.42
Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: a follow-up study. J Clin Microbiol (1988) 1.20
An ELISA to detect antipseudomonal IgA antibodies in sera of patients with cystic fibrosis. J Clin Pathol (1988) 0.97
IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis. Acta Pathol Microbiol Scand C (1979) 0.91
A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother (1997) 2.63
Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee. Arch Dis Child (1997) 2.12
Food intolerance and food allergy in children: a review of 68 cases. Arch Dis Child (1982) 2.07
Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis. Lancet (1985) 1.86
Immune responses to Helicobacter pylori in children with recurrent abdominal pain. J Clin Pathol (1991) 1.84
Incidence of neonatal urinary tract infection. Arch Dis Child (1969) 1.79
Admission to hospital with asthma. Arch Dis Child (1985) 1.77
Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples. J Clin Microbiol (1998) 1.77
Home intravenous antibiotic treatment in cystic fibrosis. Arch Dis Child (1988) 1.72
Differential diagnosis in child sexual abuse. Lancet (1987) 1.64
The sweat test. Arch Dis Child (1986) 1.58
Serious infection caused by group C streptococci. J Clin Pathol (1980) 1.56
Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom. Arch Dis Child (1990) 1.55
Prevalence of bacteriuria in infants and preschool children. Lancet (1974) 1.53
Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis. Pediatr Pulmonol (2000) 1.50
Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis. Arch Dis Child (1986) 1.49
Vitamin status in treated patients with cystic fibrosis. Arch Dis Child (1981) 1.45
Serum IgG antibodies in patients with cystic fibrosis with early Pseudomonas aeruginosa infection. Arch Dis Child (1987) 1.42
Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child (1987) 1.38
Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate. Lancet (1988) 1.29
Cystic fibrosis and allergic bronchopulmonary aspergillosis. Arch Dis Child (1990) 1.23
The value of serum IgG titres against Pseudomonas aeruginosa in the management of early pseudomonal infection in cystic fibrosis. Arch Dis Child (1992) 1.21
Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: a follow-up study. J Clin Microbiol (1988) 1.20
Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis. J Clin Pathol (1986) 1.19
66 infants with urinary tract infection in first month of life. Arch Dis Child (1972) 1.19
Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis (1996) 1.19
A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis. Arch Dis Child (1993) 1.16
Urinary tract infection by Trichomonas vaginalis in a newborn baby. Arch Dis Child (1966) 1.14
Colonic strictures in cystic fibrosis. Arch Dis Child (1995) 1.13
Clinical monitoring of steatorrhoea in cystic fibrosis. Arch Dis Child (1990) 1.13
A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther (1997) 1.11
Totally implantable venous access systems in paediatric practice. Arch Dis Child (1989) 1.09
Height and weight in cystic fibrosis: a cross sectional study. UK Cystic Fibrosis Survey Management Committee. Arch Dis Child (1997) 1.06
Two tier screen for cystic fibrosis. Lancet (1981) 1.06
Campylobacter pylori gastritis. Arch Dis Child (1988) 1.05
Acute severe deterioration in cystic fibrosis associated with influenza A virus infection. Thorax (1992) 1.04
Defective neutrophil function and microbicidal mechanisms in the myelodysplastic disorders. J Clin Pathol (1983) 1.04
Routine colonoscopy service. Arch Dis Child (1984) 1.03
Ultrasonography of the pancreas, liver, and biliary system in cystic fibrosis. Arch Dis Child (1984) 1.03
Misdiagnosis of cystic fibrosis. Arch Dis Child (1987) 1.03
Dornase alfa for cystic fibrosis. Patients should not be denied a safe, effective treatment. BMJ (1995) 1.02
Stool microscopy in screening for steatorrhoea. J Clin Pathol (1977) 1.02
Plasma vitamin K1 concentrations in cystic fibrosis. Arch Dis Child (1989) 1.02
An outbreak of acinetobacter septicaemia in a neonatal intensive care unit. J Hosp Infect (1989) 1.01
Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin. Acta Paediatr Scand (1985) 1.00
Comparison of the diagnostic value of serum pancreatic isoamylase and immunoreactive trypsin measurement in patients with cystic fibrosis. J Clin Pathol (1982) 1.00
Comparison of treatments for congenital nonobstructive nonhaemolytic hyperbilirubinaemia. Arch Dis Child (1975) 0.98
Serial C-reactive protein measurements in infective complications following cardiac operation: evaluation and use in monitoring response to therapy. Ann Thorac Surg (1982) 0.98
Antimicrobial susceptibilities of bacteria associated with periodontal disease. Antimicrob Agents Chemother (1983) 0.97
An ELISA to detect antipseudomonal IgA antibodies in sera of patients with cystic fibrosis. J Clin Pathol (1988) 0.97
Markers for faecal fat estimation in monitoring steatorrhoea in cystic fibrosis. Gut (1988) 0.96
Controlled trial of house dust mite avoidance in children with mild to moderate asthma. Clin Allergy (1987) 0.95
Ileal pH in cystic fibrosis. Scand J Gastroenterol Suppl (1988) 0.95
Treatment of Bartter's syndrome in early childhood with prostaglandin synthetase inhibitors. Arch Dis Child (1978) 0.93
Cystic fibrosis in Asians. Arch Dis Child (1993) 0.93
Microbicidal function of the neutrophils in hairy-cell leukaemia. Acta Haematol (1979) 0.92
Long term phototherapy in Crigler-Najjar syndrome. Arch Dis Child (1983) 0.92
Generalized pruritus in a baby as a presenting feature of the arteriohepatic dysplasia syndrome. Clin Exp Dermatol (1983) 0.92
Candida infection of the urinary tract. Case report, with a review of the literature and a study of frequency of yeast isolations from the urine of children with bacterial urinary infections. Br J Urol (1968) 0.91
Some factors influencing the efficiency of a jet nebuliser system. Clin Phys Physiol Meas (1990) 0.89
Nebulised amiloride in respiratory exacerbations of cystic fibrosis: a randomised controlled trial. Arch Dis Child (1995) 0.89
Allergic bronchopulmonary aspergillosis. Lancet (1990) 0.88
A normal fat diet for cystic fibrosis: is a dietitian still needed? Scand J Gastroenterol Suppl (1988) 0.88
The role of hepatobiliary scintigraphy in cystic fibrosis. Hepatology (1996) 0.88
Maple syrup urine disease. Four years' experience with dietary treatment of a case. Acta Paediatr Scand (1969) 0.87
Improved isolation of Stenotrophomonas maltophilia from the sputa of patients with cystic fibrosis using a selective medium. Clin Microbiol Infect (2000) 0.87
Enteric-coated prednisolone in cystic fibrosis. Lancet (1986) 0.87
Antibiotics in surgical treatment of acute abscesses. Br Med J (1980) 0.87
Survival estimates for adults with cystic fibrosis born in the United Kingdom between 1947 and 1967. The UK Cystic Fibrosis Survey Management Committee. Thorax (1999) 0.86
Interpretation of sweat sodium and chloride concentrations. Ann Clin Biochem (1986) 0.86
Aspergillus fumigatus colonisation and population density of place of residence in cystic fibrosis. Arch Dis Child (1994) 0.85
Essential element nutritional status in cystic fibrosis. Hum Nutr Appl Nutr (1986) 0.84
Defective microbicidal function of neutrophils in haematological malignancies and lymphomas: correction by levamisole in vitro. Biomedicine (1978) 0.84
Iron deficiency in cystic fibrosis. Arch Dis Child (1987) 0.84
Management and response to treatment of Helicobacter pylori gastritis. Arch Dis Child (1992) 0.83
Comparative study of cefamandole versus ampicillin plus cloxacillin: prophylactic antibiotics in cardiac surgery. Ann Thorac Surg (1982) 0.82
Resting energy expenditure and substrate oxidation rates in cystic fibrosis. Arch Dis Child (1993) 0.82
Ocular signs and symptoms and vitamin A status in patients with cystic fibrosis treated with daily vitamin A supplements. Br J Ophthalmol (1999) 0.82
Stable isotope studies of pancreatic enzyme release in vivo. Postgrad Med J (1996) 0.82
The diagnosis of cystic fibrosis. Practitioner (1980) 0.81
Small intestinal bacterial growth in systemic sclerosis. Clin Exp Dermatol (1980) 0.81
Scoliosis in cystic fibrosis: is it idiopathic? Spine (Phila Pa 1976) (2004) 0.81
A case of beta-ketothiolase deficiency. J Inherit Metab Dis (1983) 0.81
A new neutrophil candida killing test: chromium-51 release from Candida guilliermondii. J Clin Pathol (1980) 0.81
Recurrent abdominal pain and lactose intolerance in childhood. Br Med J (Clin Res Ed) (1981) 0.81
The clinical picture of coexisting toxoplasma and toxocara infection and its management. A small child with a rare double infection. Clin Pediatr (Phila) (1976) 0.81
Use of enoxacin in a patient with cystic fibrosis. Lancet (1985) 0.80
An overview of the management of cystic fibrosis. J R Soc Med (1986) 0.80
Aztreonam therapy in children with febrile neutropenia: a randomized trial of aztreonam plus flucloxacillin versus piperacillin plus gentamicin. J Antimicrob Chemother (1991) 0.80
Establishment of minimum inhibitory concentrations of cefoperazone for control and reference anaerobic organisms. J Clin Microbiol (1983) 0.80
Aerobic and anaerobic bacteriology of subcutaneous abscesses. Br J Surg (1981) 0.80